Tag Archives: Conatus

Equities Analysts Issue Forecasts for Conatus Pharmaceuticals Inc’s Q1 2016 Earnings (CNAT)

Equities Analysts Issue Forecasts for Conatus Pharmaceuticals Inc's Q1 2016 Earnings (CNAT) Zacks Investment Research reports. FBR & Co. analyst V. Bernardino expects that the brokerage will post earnings per share of ($ 0.33) for the quarter. FBR & Co. has a "Outperform" rating and a $ 16.00 price target on the stock. The consensus Read more
Category: Earnings
Wordpress SEO Plugin by SEOPressor